Simplify Logo

Full-Time

Sci II / Senior Scientist

Discovery Gene Therapy Research

Posted on 4/18/2024

Fractyl Health, Inc

Fractyl Health, Inc

51-200 employees

Develops therapies for type 2 diabetes management

Hardware
Biotechnology
Healthcare

Senior

Burlington, MA, USA

Category
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD in Biology, Biomedical engineering, or other relevant research fields
  • 3-5+ years of highly relevant post-PhD experience
  • Extensive experience with mammalian cell culture, DNA transfection, and viral transduction
  • Expertise in DNA construct design
  • Experience in molecular assays quantitating gene expression levels
  • Experience with molecular and cellular biology techniques
  • Experience in metabolic disease research
  • Experience with small and large animal models
  • Track record of contributing to programs from discovery research to IND/CTA
  • Hands-on experience and expertise
  • Excellent verbal and written communication skills
  • Proven track record as a team-player and collaborator
  • Highly organized and detail-oriented
  • Self-motivated and able to work independently
  • Innovation and creative problem-solving skills
  • Professionalism, confidence, and ethical standards
Responsibilities
  • Contribute to the characterization of lead gene therapy program
  • Design and optimize genetic constructs
  • Perform in vitro screening
  • Develop and conduct molecular assays
  • Support biodistribution and transgene expression data generation
  • Prepare technical reports and protocols
  • Maintain electronic lab notebook
  • Identify and bring new technologies to support gene therapy mission
  • Mentor and develop junior research scientists
  • Perform activities in compliance with regulations and policies
  • Deliver on assigned responsibilities

Fractyl Health is pioneering Revita, an endoscopic procedural therapy that targets the root causes of type 2 diabetes by remodeling the duodenal lining via hydrothermal ablation. They are also developing Rejuva, a novel pancreatic gene therapy platform aimed at restoring insulin production and islet function in patients with advanced type 2 diabetes.

Company Stage

IPO

Total Funding

$395.4M

Headquarters

Lexington, Kentucky

Founded

2010

Growth & Insights
Headcount

6 month growth

21%

1 year growth

20%

2 year growth

27%
INACTIVE